Do p38 mitogen-activated protein kinase inhibitors have a future for the treatment of cardiovascular disease?

Por Kompa, Andrew R.
Publicado no J Thorac Dis (2016)

Desensitization and resensitization of β(1)- and putative β(4)-adrenoceptor mediated responses occur in parallel in a rat model of cardiac failure

Por Kompa, Andrew R, Summers, Roger J
Publicado em 1999

Inotropic responses to human gene 2 (B29) relaxin in a rat model of myocardial infarction (MI): effect of pertussis toxin

Por Kompa, Andrew R, Samuel, Chrishan S, Summers, Roger J
Publicado em 2002

The Uremic Toxin Adsorbent AST-120 Abrogates Cardiorenal Injury Following Myocardial Infarction

Por Lekawanvijit, Suree, Kumfu, Sirinart, Wang, Bing H., Manabe, Minako, Nishijima, Fuyuhiko, Kelly, Darren J., Krum, Henry, Kompa, Andrew R.
Publicado em 2013

Renin-Angiotensin Blockade Combined With Natriuretic Peptide System Augmentation: Novel Therapeutic Concepts to Combat Heart Failure

Por von Lueder, Thomas G., Sangaralingham, S. Jeson, Wang, Bing H., Kompa, Andrew R., Atar, Dan, Burnett, John C., Krum, Henry
Publicado em 2013

Chronic Kidney Disease-Induced Cardiac Fibrosis Is Ameliorated by Reducing Circulating Levels of a Non-Dialysable Uremic Toxin, Indoxyl Sulfate

Por Lekawanvijit, Suree, Kompa, Andrew R., Manabe, Minako, Wang, Bing H., Langham, Robyn G., Nishijima, Fuyuhiko, Kelly, Darren J., Krum, Henry
Publicado em 2012

Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxins

Por Rana, Indrajeetsinh, Kompa, Andrew R, Skommer, Joanna, Wang, Bing H, Lekawanvijit, Suree, Kelly, Darren J, Krum, Henry, Charchar, Fadi J
Publicado no Physiol Rep (2015)

Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxins

Por Rana, Indrajeetsinh, Kompa, Andrew R., Skommer, Joanna, Wang, Bing H., Lekawanvijit, Suree, Kelly, Darren J., Krum, Henry, Charchar, Fadi J.
Publicado no Physiol Rep (2015)